Franchise GP Ltd Purchases Shares of 14,660 Lam Research Corporation $LRCX

Franchise GP Ltd acquired a new position in Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, Holdings Channel reports. The firm acquired 14,660 shares of the semiconductor company’s stock, valued at approximately $6,353,000. Lam Research accounts for 3.0% of Franchise GP Ltd’s holdings, making the stock its 12th largest holding.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC increased its holdings in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Caxton Associates LLP purchased a new position in shares of Lam Research during the 1st quarter worth $239,000. Gabelli Funds LLC bought a new stake in shares of Lam Research during the 2nd quarter valued at $253,000. NewEdge Advisors LLC grew its position in shares of Lam Research by 2.7% during the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after acquiring an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. increased its stake in shares of Lam Research by 5,206.7% in the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after purchasing an additional 781 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Trading Up 1.1%

Shares of LRCX stock opened at $310.53 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The stock has a fifty day simple moving average of $338.53 and a two-hundred day simple moving average of $285.89. The firm has a market capitalization of $388.57 billion, a PE ratio of 53.91, a PEG ratio of 1.22 and a beta of 1.84. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business’s revenue was up 30.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

Analyst Ratings Changes

LRCX has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $320.00 target price on shares of Lam Research in a report on Thursday, July 30th. Oppenheimer restated an “outperform” rating and issued a $400.00 price target (up from $330.00) on shares of Lam Research in a research report on Monday, June 15th. Bank of America raised their price objective on Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. Raymond James Financial set a $425.00 price objective on Lam Research in a research report on Wednesday, June 10th. Finally, Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the company a “buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and a consensus price target of $358.47.

Insider Buying and Selling

In other Lam Research news, SVP Neil J. Fernandes sold 7,659 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. This represents a 11.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 80,441 shares of company stock valued at $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.